Latest Releases
U.S. Senators Tina Smith, Ron Wyden Re-Introduce Legislation to Strengthen Mental Health Care Coverage, Hold Insurance Companies Accountable
WASHINGTON — Last week, U.S. Senators Tina Smith (D-MN) and Ron Wyden (D-OR) introduced legislation to improve coverage for mental health and substance use disorder care. Specifically, the Behavioral Health Network and Directory Improvement Act would crack down on health insurance tactics of posting incomplete, inaccurate lists of providers – called “ghost networks”— and create stronger enforcement standards to protect those seeking mental health care. “Mental health needs to be treated with the same urgency as physical health, and that means making sure everyone has access to the mental health care they need without unnecessary delays and barriers,” said Sen. Smith. “By law, insurance companies should cover mental health just like they cover physical health, yet they’re still finding ways to dodge compliance and deny coverage to customers. By setting stricter standards and holding insurance companies accountable for inaccurate listings, this legislation will help ensure people have access to the mental health care coverage they deserve.” “Amid a nationwide mental health crisis, it’s outrageous how common it is for people in need of treatment to find that their health insurance is almost useless when they try to see a mental health provider,” said Sen. Wyden. “In the worst cases these ghost networks are essentially a fraudulent product, but health insurance companies continue to sell those policies for top dollar. In just about any other industry, the customer would be owed a refund. This bill is about closing gaps in federal law and establishing real accountability for health insurance companies that continue to sell these ghost network insurance policies.” Ghost health care provider networks are providers listed by private insurance companies as
U.S. Senators Amy Klobuchar, Tina Smith Join Colleagues in Pushing a Framework for U.S. Recognition of a Nonmilitarized Palestinian State
[WASHINGTON] – In light of the ongoing negotiations around a humanitarian ceasefire in Gaza, U.S. Senators Amy Klobuchar and Tina Smith joined a letter with 17 of their Senate colleagues to the Biden Administration, urging the President to establish a public framework for the U.S. to recognize a nonmilitarized Palestinian state. As a strong diplomatic leader in the region for decades, the U.S. must continue this role and take concrete action toward a two-state solution, in line with established U.S. foreign policy. “Given the severity of the current crisis, this moment requires determined U.S. leadership that must move beyond facilitation. As such, we request the Biden Administration promptly establish a bold, public framework outlining the steps necessary for the U.S. to recognize a nonmilitarized Palestinian state, which includes the West Bank and Gaza, to be governed by a revitalized and reformed Palestinian Authority,” the Senators write. They continue: “The diplomatic steps that you and your Administration have taken have been of utmost importance, and we urge you to do even more. We believe it is critical at this moment for the United States to signal our willingness to lead a regional peace initiative that would eventually result in U.S. recognition of a nonmilitarized Palestinian state, as well as Israel’s full integration into the region. The road to enduring peace in the region depends entirely on the two-state solution—the establishment of a Palestinian state, existing in concert with a regionally-integrated Israel. Despite decades of U.S. support for this policy, there has been limited success
Klobuchar, Smith Urge U.S. Department of Agriculture to Help Minnesota Farmers Respond to Avian Flu Outbreak
WASHINGTON – U.S. Senators Amy Klobuchar (D-MN) and Tina Smith (D-MN), both members of the Senate Agriculture Committee, urged the U.S. Department of Agriculture (USDA) to ensure that the Animal and Plant Health Inspection Service (APHIS) helps Minnesota farmers respond to the recent avian influenza (HPAI) outbreak. “We write with concern about the rapid spread of the H5N1 Highly Pathogenic Avian Influenza (HPAI) virus that has been confirmed in 19 commercial turkey flocks and 2 backyard flocks in 11 counties across Minnesota, already killing over a million birds,” the lawmakers wrote to Secretary of Agriculture Tom Vilsack. “As the number
U.S. Senator Tina Smith’s Statement on the Vote to Confirm of Justice Ketanji Brown Jackson
WASHINGTON, D.C. [04/07/22]—Today, U.S. Senator Tina Smith (D-Minn.) released the following statement on the bipartisan confirmation of Justice Ketanji Brown Jackson to the Supreme Court of the United States: “I had a front row seat to history today as the Senate voted to confirm Judge Ketanji Brown Jackson to the Supreme Court. “I was proud to vote to confirm Judge Jackson, the first Black woman and first former federal public defender to serve on the Supreme Court. Judge Jackson showed character, intellect, and grace through the entire confirmation process. She is a brilliant legal mind and has stellar credentials as
Sens. Smith, Stabenow, and Rep. Maloney Lead Colleagues in Introducing Bicameral Package of Legislation to Target Abusive Pharmaceutical Business Practices
Washington, D.C. [04.07.22]—Today, Sens. Tins Smith (D-MN), Debbie Stabenow (D-MI), and Rep. Carolyn B. Maloney (D-NY-12), led colleagues—including Rep. Peter Welch and Rep. Jan Schakowsky—in introducing a package of legislation targeting business practices pharmaceutical companies use to suppress competition, maintain market monopolies, and keep drug prices high. The legislative reforms follow the Oversight Committee’s three-year investigation into pharmaceutical pricing and business practices that exposed pharmaceutical company practices to suppress competition from lower-priced generics and biosimilars and make drug prices unaffordable for many Americans. “There is no good reason Americans should be paying more than any country in the world for
Sens. Smith, Stabenow, and Rep. Maloney Lead Colleagues in Introducing Bicameral Package of Legislation to Target Abusive Pharmaceutical Business Practices
Washington, D.C. [04.07.22]—Today, Sens. Tins Smith (D-MN), Debbie Stabenow (D-MI), and Rep. Carolyn B. Maloney (D-NY-12), led colleagues—including Rep. Peter Welch and Rep. Jan Schakowsky—in introducing a package of legislation targeting business practices pharmaceutical companies use to suppress competition, maintain market monopolies, and keep drug prices high. The legislative reforms follow the Oversight Committee’s three-year investigation into pharmaceutical pricing and business practices that exposed pharmaceutical company practices to suppress competition from lower-priced generics and biosimilars and make drug prices unaffordable for many Americans. “There is no good reason Americans should be paying more than any country in the world for
English